immunesk.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php | ||
Meta Tags
| Title | Immune System Key |
| Description | Developing Novel Drugs for Malignant and Auto-Immune |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 68.183.159.142 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
immunesk.com Valuation
|
US$969,056
Last updated: 2022-06-21 16:08:21
immunesk.com has Semrush global rank of 10,922,291. immunesk.com has an estimated worth of US$ 969,056, based on its estimated Ads revenue. immunesk.com receives approximately 111,815 unique visitors each day. Its web server is located in United States, with IP address 68.183.159.142. According to SiteAdvisor, immunesk.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$969,056 |
| Daily Ads Revenue | US$895 |
| Monthly Ads Revenue | US$26,836 |
| Yearly Ads Revenue | US$322,025 |
| Daily Unique Visitors | 7,455 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| immunesk.com. | A | 3599 | IP: 68.183.159.142 |
| immunesk.com. | NS | 3600 | NS Record: ns1.wix.com. |
| immunesk.com. | NS | 3600 | NS Record: ns2.wix.com. |
| immunesk.com. | MX | 3600 | MX Record: 10 immunesk-com.mail.protection.outlook.com. |
| immunesk.com. | TXT | 1800 | TXT Record: MS=ms42056736 |
| immunesk.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-21 16:08:21
| Home News & Events Science And R&D Nerofe Pipeline Technology Nerofe Mode of Action Phase I Results First Success Story Company Description Team Contact Us Home News & Events Science And R&D Nerofe Pipeline Technology Nerofe Mode of Action Phase I Results First Success Story Company Description Team Contact Us DEVELOPING NOVEL DRUGS FOR MALIGNANT AND AUTOIMMUNE DISEASES EXPLORE DEVELOPING NOVEL DRUGS FOR MALIGNANT AND AUTOIMMUNE DISEASES EXPLORE Home ariel 2019-02-25T13:39:03+00:00 Immune System Key Ltd. Immune System Key Ltd. (ISK) is a privately held company that was founded in 2005 by Prof. Uziel Sandler and Dr. Yoram Devary. It is engaged in discovery and development of innovative treatments for malignant and autoimmune diseases with strong unmet needs. ISK’s assets are based on novel human secreted peptides, which were discovered by the founders. ISK’s lead compound is Nerofe TM . Nerofe TM was granted by the FDA with orphan drug status for AML treatment and currently is in phase |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sat, 23 Oct 2021 18:12:47 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://immunesk.com/ HTTP/2 500 server: nginx date: Sat, 23 Oct 2021 18:12:47 GMT content-type: text/html; charset=iso-8859-1 |
immunesk.com Whois Information
Domain Name: IMMUNESK.COM Registry Domain ID: 1696663875_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2018-12-16T10:42:16Z Creation Date: 2012-01-12T14:08:56Z Registry Expiry Date: 2022-01-12T14:08:56Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.WIX.COM Name Server: NS2.WIX.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:12:19Z <<< |